Aalia N Khan

Aalia N Khan

Indian Institute of Technology Bombay - Mumbai / India
Engineering & Technology / Biomaterials and Tissue Engineering
AD Scientific Index ID: 5138710
भारतीय प्रौद्योगिकी संस्थान, मुंबई
person_outline Aalia N Khan's MOST POPULAR ARTICLES
1-) Immunogenicity of CAR-T cell therapeutics: evidence, mechanism and mitigationAN Khan, A Chowdhury, A Karulkar, AK Jaiswal, A Banik, S Asija, ...Frontiers in Immunology 13, 886546, 2022342022
2-) CAR‐T cell therapy in hematological malignancies: Where are we now and where are we heading for?AN Khan, S Asija, J Pendhari, R PurwarEuropean Journal of Haematology 112 (1), 6-18, 202462024
3-) Making anti-CD19 CAR-T cell therapy accessible and affordable: first-in-human phase I clinical trial experience from IndiaA Karulkar, H Jain, S Shah, A Khan, A Jaiswal, A Firfiray, P Suvasia, ...Blood 140 (Supplement 1), 4610-4611, 202262022
4-) Phase I trial of humanized CD19 CART-cell therapy developed in India: safe, active and feasible for outpatient therapyH Jain, A Karulkar, N Sharma, M Sengar, A Jaiswal, S Shah, A Khan, ...Blood 140 (Supplement 1), 10332-10334, 202242022
5-) Evaluating the safety of HCAR19 (now actalycabtagene autoleucel-Actaly-cel™), a novel humanized CD19-directed chimeric antigen receptor T-cells in pediatric, adolescents, and …G Narula, S Keerthivasagam, H Jain, C Dhamne, P Tembhare, ...Blood 142 (Supplement 1), 6878-6878, 202322023